Medicine and Dentistry
Gallbladder Cancer
100%
Gallbladder Disease
44%
Diagnostic Performance
38%
Pancreas Cancer
33%
Machine Perfusion
33%
Radiomics
33%
Liver Transplantation
33%
Neoadjuvant Therapy
33%
Chemoradiotherapy
33%
Rectum Cancer
33%
Induction Chemotherapy
33%
Arm
33%
Surgery
27%
Cholestasis
23%
Liver Parenchyma
22%
Radiation Therapy
22%
Re-Irradiation
16%
Capecitabine
16%
Oxaliplatin
16%
Neoplasm
12%
Folinic Acid
11%
FOLFOX
11%
Fluorouracil
11%
High Risk Population
9%
Neoadjuvant Chemotherapy
6%
Diagnosis
5%
Experimental Surgery
5%
Magnetic Resonance Imaging
5%
Total Mesorectal Excision
5%
Postoperative Complication
5%
Irinotecan
5%
Quality of Life
5%
Chemotherapy Agent
5%
FOLFIRI
5%
Health Care Cost
5%
Disease
5%
Prognostic Factor
5%
Distant Metastasis
5%
Keyphrases
Gallbladder Lesions
66%
Benign Gallbladder Disease
38%
Deep Learning
33%
Gallbladder Cancer
33%
Lesion Characterization
33%
Convolutional Neural Network
33%
Gallbladder
27%
Liver Parenchyma
22%
CT-based
11%
Total Mesorectal Resection
6%
Visual Interpretation
5%
Borderline Resectable
5%
Diagnostic Results
5%
Result-oriented
5%
Portal Venous Phase
5%
Computed Tomography
5%
Pathological Diagnosis
5%
Contrast Enhancement
5%
Consecutive Patients
5%
Visual Prediction
5%
Boosting Classifier
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chemoradiation Therapy
33%
Chemotherapy
33%
Rectum Cancer
33%
Oxaliplatin
20%
Capecitabine
20%
Fluorouracil
13%
Folinic Acid
13%
Disease
6%
Distant Metastasis
6%
Irinotecan
6%
Chemotherapy Agent
6%
Neoplasm
6%
Postoperative Complication
6%
